Monday, September 16, 2019

Microglia Alternations can cause Depressive-like Behaviors


This paper discusses how changes to microglia activity could cause depressive-like behaviors. Kreisel et al. investigated this by measuring the results of chronic stress procedures on mice and rats. They studied behavioral, pharmacological, molecular, and biochemical responses to those procedures. They found that after mice underwent chronic unpredictable stress (CUS) and rats underwent chronic mild stress (CMS), they displayed more depressive like symptoms such as decreased sucrose preference and social exploration. They also found a decrease in microglia in the hippocampus and increased levels of corticosterone. Kreisel et al. found differences in results when animals were exposed to short-term unpredictable stress. They found an initial increase in microglia number in the initial stage of the unpredictable stress procedure, and then a decrease of microglia at the later stages of the procedure. Kreisel et al. further studied how anti-depressants could reverse the behavioral and molecular affects of stress. Minocycline and Imipramine were able to increase microglia number, prevented the suppressive effects of sucrose preference and social exploration, and increased IL-1 signaling which confirms microglia activation. Lastly, Kreisel et al. studied the effects of microglia stimulation on depressive-like symptoms, and whether anti-psychotic drugs were able to reverse these symptoms after CUS exposed mice established depressive like symptoms, as opposed to during the CUS procedure. Microglia stimulation by different microglia activators showed mixed results; LPS improved some depressive like behavior such as in the open field test while also did not change other types of behavior like sucrose preference and social exploration. Another activator, M-CSF was able to improve sucrose preference and social exploration. Anti-psychotic drugs were able to improve some depressive behaviors and not others.
I found this paper very interesting because it aims to discover the link between nonneuronal cells like microglia to psychiatric disorders like depression. There is so little that we know behind neuropsychopathology of these disorders and I like that Kreisel et al. sought to study this. I also found it interesting that different types of depressive behaviors were improve by the antipsychotics while others did not, even though microglia number and activation increased. Different depressive symptoms may have different neuropsychopathology than others which may explain the differences. This goes to show how complex it is to study neuropsychiatric disorders. Additionally, since microglia takes part in the immune system in the brain, this paper finds more relationships between immunity and behavioral functioning. The immune system may play a bigger role than we think when it comes to psychiatric disorders and may explain how many illnesses are comorbid with psychiatric disorders. Lastly, Kreisel et al. found differences between microglia number during different stages of the CUS procedure. The beginning stages showed increase in number and the later stages did not. Also, the antipsychotic drugs were able to reverse depressive like symptoms in the earlier stags as opposed to when the CUS-mice already had established depressive like symptoms. These findings could provide insight on what treatment is best for a patient with depression depending on what stage of the disorder they are in, and based on what symptoms they have.
Some critiques I have were that Kreisel et al. only used male animals in this study and they had a small sample size. There data also may not be representative in a clinical setting because of the use of animals, not humans. There are also sex differences found in those with major depressive disorder and using female animals in this study could had addressed these. The paper also did not fully address the biological mechanisms that take place when microglia is activated during stressful situations. More studies with diverse and human subjects which aim to find these mechanisms can provide more insight on finding treatments for different depressive symptoms, and can hopefully improve psychiatric care.

1 comment:

Note: Only a member of this blog may post a comment.